AAAAAA
Results:
1-25
|
Results: 25
Authors:
Du Toit, D
Aavik, E
Taskinen, E
Myburgh, E
Aaltola, E
Aimonen, M
Aavik, S
van Wyk, J
Hayry, P
Citation: D. Du Toit et al., Structure of carotid artery in baboon and rat and differences in their response to endothelial denudation angioplasty, ANN MED, 33(1), 2001, pp. 63-78
Authors:
Aavik, E
du Toit, D
Myburgh, E
Frosen, J
Hayry, P
Citation: E. Aavik et al., Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury, MOL C ENDOC, 182(1), 2001, pp. 91-98
Authors:
Hayry, P
Citation: P. Hayry, New targets for the prevention of transplant vascular disease, TRANSPLAN P, 33(3), 2001, pp. 2332-2333
Authors:
Hayry, P
Aavik, E
Palgi, M
Petrov, L
Savolainen, H
Luoto, NM
Loubtchenkov, M
Frosen, J
Citation: P. Hayry et al., Molecular biology of transplant arteriosclerosis and sites of therapeutic intervention, TRANSPLAN P, 33(1-2), 2001, pp. 293-294
Authors:
Savolainen, H
Frosen, J
Petrov, L
Hayry, P
Citation: H. Savolainen et al., Expression of the vasculoprotective estrogen receptor subtype beta in rat and human cardiac allograft vasculopathy, TRANSPLAN P, 33(1-2), 2001, pp. 1605-1605
Authors:
Kirveskari, J
Paavonen, T
Hayry, P
Renkonen, R
Citation: J. Kirveskari et al., De novo induction of endothelial L-selectin ligands during kidney allograft rejection, J AM S NEPH, 11(12), 2000, pp. 2358-2365
Authors:
Hayry, P
Savolainen, H
Luoto, NM
Petrov, L
Loubtchenkov, M
Aavik, E
Citation: P. Hayry et al., Emerging therapeutic strategies for the prevention and treatment of chronic allograft rejection, TRANSPLAN P, 32(3), 2000, pp. 519-519
Authors:
Yilmaz, S
Taskinen, E
Paavonen, T
Hayry, P
Citation: S. Yilmaz et al., Protocol core biopsy (CADI): A surrogate marker for chronic rejection, TRANSPLAN P, 32(1A), 2000, pp. 12S-12S
Authors:
Hayry, P
Citation: P. Hayry, Pathology makes the difference, TRANSPLANT, 69(6), 2000, pp. 1038-1040
Authors:
Myllarniemi, M
Frosen, J
Ramirez, LGC
Buchdunger, E
Lemstrom, K
Hayry, P
Citation: M. Myllarniemi et al., Selective tyrosine kinase inhibitor for the platelet-derived growth factorreceptor in vitro inhibits smooth muscle cell proliferation after reinjuryof arterial intima in vivo, CARDIO DRUG, 13(2), 1999, pp. 159-168
Authors:
Khare, S
Kumar, U
Sasi, R
Puebla, L
Calderon, L
Lemstrom, K
Hayry, P
Patel, YC
Citation: S. Khare et al., Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty, FASEB J, 13(2), 1999, pp. 387-394
Authors:
Hayry, P
Aavik, E
Savolainen, H
Citation: P. Hayry et al., Mechanisms of chronic rejection, TRANSPLAN P, 31(7A), 1999, pp. 5S-8S
Authors:
Hayry, P
Citation: P. Hayry, Pathophysiology and diagnosis of acute rejection, TRANSPLAN P, 31(4), 1999, pp. 1789-1789
Authors:
Hayry, P
Citation: P. Hayry, Chronic rejection: New potential venues of therapy, TRANSPLAN P, 31(4), 1999, pp. 1799-1800
Authors:
Hayry, P
Citation: P. Hayry, The XVII World Congress of the Transplantation Society: New visions and new solutions, TRANSPLAN P, 31(1-2), 1999, pp. 5-6
Authors:
Koskinen, P
Sihvola, R
Myllarniemi, M
Hayry, P
Buchdunger, E
Lemstrom, K
Citation: P. Koskinen et al., Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor, TRANSPLAN P, 31(1-2), 1999, pp. 102-102
Authors:
Delafontaine, P
Brink, M
Anwar, A
Hayry, P
Okura, Y
Citation: P. Delafontaine et al., Growth factors and receptors in allograft arteriosclerosis, TRANSPLAN P, 31(1-2), 1999, pp. 111-114
Authors:
Kallio, E
Lemstrom, K
Ryan, U
Hayry, P
Koskinen, P
Citation: E. Kallio et al., Inhibition of complement reduces obliterative bronchiolitis, TRANSPLAN P, 31(1-2), 1999, pp. 188-188
Authors:
Hayry, P
Citation: P. Hayry, Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist - Relax-relax, TRANSPLANT, 68(6), 1999, pp. 729-730
Authors:
Otonkoski, T
Ustinov, J
Rasilainen, S
Kallio, E
Korsgren, O
Hayry, P
Citation: T. Otonkoski et al., Differentiation and maturation of porcine fetal islet cells in vitro and after transplantation, TRANSPLANT, 68(11), 1999, pp. 1674-1683
Authors:
Makela, S
Savolainen, H
Aavik, E
Myllarniemi, M
Strauss, L
Taskinen, E
Gustafsson, JA
Hayry, P
Citation: S. Makela et al., Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta, P NAS US, 96(12), 1999, pp. 7077-7082
Authors:
Sihvola, R
Koskinen, P
Myllarniemi, M
Loubtchenkov, M
Hayry, P
Buchdunger, E
Lemstrom, K
Citation: R. Sihvola et al., Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor, CIRCULATION, 99(17), 1999, pp. 2295-2301
Authors:
Toppila, S
Paavonen, T
Nieminen, MS
Hayry, P
Renkonen, R
Citation: S. Toppila et al., Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants, AM J PATH, 155(4), 1999, pp. 1303-1310
Authors:
Hayry, P
Citation: P. Hayry, Chronic allograft vasculopathy new strategies for drug development, TRANSPLAN P, 30(8), 1998, pp. 3989-3990
Authors:
Hayry, P
Citation: P. Hayry, Chronic rejection: An update on the mechanism, TRANSPLAN P, 30(8), 1998, pp. 3993-3995
Risultati:
1-25
|